Morgan Stanley filings document the company’s financial services business, capital structure, governance and material events. The record includes 8-K reports for current events, proxy materials for annual meeting and shareholder voting matters, and securities listings covering common stock, depositary preferred shares and medium-term notes associated with Morgan Stanley Finance LLC.
Filings also disclose governance procedures, registered security classes, NYSE listing information, preferred stock series, debt-security registration matters and formal status changes such as a Form 25 notice for removal of a listed note class from exchange registration.
Morgan Stanley Finance LLC priced $500,000 of principal-at-risk, contingent-income, auto-callable securities linked to Blackstone Inc. common stock. Each security has a $1,000 original issue price and matures on April 5, 2029, with a 14.25% annual contingent coupon and automatic early‑redemption dates beginning October 7, 2026. Coupons pay only if the closing level meets the coupon barrier ($56.525, 50% of the initial level) on observation dates; principal is at risk if the final level is below the downside threshold ($56.525), producing a payment equal to the stated principal multiplied by the performance factor (final level/initial level).
Morgan Stanley Finance LLC is offering structured market-linked notes due April 24, 2031 that are fully and unconditionally guaranteed by Morgan Stanley and pay no interest. The notes reference a basket equally weighted among Blackstone Inc., KKR & Co. Inc. and Ares Management Corporation, have a 200% participation rate in appreciation and a maximum payment at maturity of $1,520 per $1,000 note. The notes return principal at maturity if the final level is equal to or below the initial level; upside is paid only if the final level is greater than the initial level measured on the observation date. The estimated value on the pricing date is approximately $934.90 per note. All payments are subject to Morgan Stanley’s credit risk; the notes are unsecured, will not be listed, and include sales and structuring fees deducted from the issue price.
Morgan Stanley Finance LLC priced a Preliminary Pricing Supplement for a series of Buffered PLUS principal-at-risk securities tied to the S&P 500® Futures Excess Return Index. Each security has a $1,000 stated principal amount and an estimated value of approximately $940 on the pricing date. The securities offer a leveraged upside equal to a 161% leverage factor on positive index performance, a 20% buffer on initial losses and a 20% minimum payment at maturity. Payment at maturity depends solely on the closing index level on the observation date, April 10, 2031, and all payments are unsecured and subject to MSFL's and Morgan Stanley's credit risk.
Morgan Stanley files a prospectus addendum and accompanying prospectus supplement dated April 8, 2026 for its Global Medium-Term Notes, Series J and K. The addendum clarifies that the April 8, 2026 prospectus and supplement supersede earlier versions and may be used in market-making transactions.
The notes are not bank deposits, are not FDIC-insured, and are not guaranteed by any bank or government agency.
Morgan Stanley published a prospectus addendum dated April 8, 2026 for Global Medium-Term Notes, Series A, Global Units, Series A and Global Warrants, Series A. The addendum and accompanying prospectus supplement supersede earlier prospectuses and may be used for market-making transactions in previously issued notes, units or warrants.
Morgan Stanley filed a prospectus addendum and accompanying prospectus supplement and prospectus dated April 8, 2026 for Global Medium-Term Notes, Series I. The addendum permits use of these documents in connection with market-making transactions in notes originally issued under earlier, similar documents.
Morgan Stanley files a Prospectus Addendum dated April 8, 2026 for Global Medium-Term Notes, Series G and H and Global Units, Series G and H. The addendum states that the accompanying prospectus dated April 8, 2026 supersedes any earlier prospectus when used for market-making transactions and that specific terms appear in prospectus supplements or pricing supplements.
Morgan Stanley files a prospectus addendum and accompanying prospectus supplement dated April 8, 2026 for Global Medium-Term Notes, Series F, Global Units, Series F and Global Warrants, Series F. The addendum clarifies that the April 8, 2026 prospectus and supplement supersede earlier versions for market-making transactions.
Morgan Stanley provides a prospectus addendum dated April 8, 2026 that supersedes earlier prospectuses when used for market-making transactions in its Global Medium-Term Notes, Series C and Global Units, Series C. The addendum directs readers to the applicable prospectus supplement or pricing supplement for specific terms.